DCVC's Therapeutics Portfolio

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

Stemson Therapeutics is a pre-clinical stage cell therapy company.

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

NILO Therapeutics is a biotechnology and therapeutics company.

A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform

Agenovir is developing novel antiviral therapeutics for diseases associated with viral reservoirs